{"id":483848,"title":"Appendices: Handbook for health care professionals on biosimilar biologic drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T22:29:47.140000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/appendices.html?wbdisable=true","snippet":"Handbook for health care professionals on biosimilar biologic drugs: Appendices Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Glossary Definitions Glossary ADA anti-drug…","rawSnapshotUrl":"/api/snapshots/raw/483848","browseUrl":"https://replay.healtharchive.ca/job-6/20260106222947/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/appendices.html?wbdisable=true#ha_snapshot=483848","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}